p53 expression predicts dismal outcome for medulloblastoma patients with metastatic disease

TP53 Mutations in Favorable-Risk Wnt/Wingless-Subtype Medulloblastomas

(2011) Janet C. Lindsey et al.   JOURNAL OF CLINICAL ONCOLOGY

Childhood medulloblastoma: novel approaches to the classification of a heterogeneous disease

(2010) David W. Ellison   ACTA NEUROPATHOLOGICA

Survival and Prognostic Factors of Early Childhood Medulloblastoma: An International Meta-Analysis

(2010) Stefan Rutkowski et al.   JOURNAL OF CLINICAL ONCOLOGY

Universal Poor Survival in Children With Medulloblastoma Harboring SomaticTP53Mutations

(2010) Uri Tabori et al.   JOURNAL OF CLINICAL ONCOLOGY

TP53 Mutation Is Frequently Associated With CTNNB1 Mutation or MYCN Amplification and Is Compatible With Long-Term Survival in Medulloblastoma

(2010) Elke Pfaff et al.   JOURNAL OF CLINICAL ONCOLOGY

p53 family members in cancer diagnosis and treatment

(2010) Alice Machado-Silva et al.   SEMINARS IN CANCER BIOLOGY

Clinical Outcomes and Correlates of TP53 Mutations and Cancer

(2009) A. I. Robles et al.   Cold Spring Harbor Perspectives in Biology

Genetically Engineered Mouse Models of Brain Cancer and the Promise of Preclinical Testing

(2008) Jason T. Huse et al.   BRAIN PATHOLOGY